Podcast
Questions and Answers
What does "pharmacovigilance" mean?
What does "pharmacovigilance" mean?
Pharmacovigilance refers to the science and activities related to the detection, evaluation, understanding, and prevention of adverse drug reactions or any other drug-related problems.
What are the primary aims of pharmacovigilance? (Select all that apply)
What are the primary aims of pharmacovigilance? (Select all that apply)
- Identification of risk factors associated with drug use (correct)
- Quantifying the risks associated with drug use (correct)
- Preventing patients from being affected unnecessarily by adverse drug reactions (correct)
- Detection of increases in frequency of adverse events (correct)
- Early detection of unknown safety problems (correct)
What event led to the passing of the Biologics Control Act in 1902?
What event led to the passing of the Biologics Control Act in 1902?
The death of multiple children due to contaminated vaccines, which were produced from horses, led to the passing of the Biologics Control Act in 1902.
What event led to the passing of the Federal Food, Drug, and Cosmetic Act in 1938?
What event led to the passing of the Federal Food, Drug, and Cosmetic Act in 1938?
What was the core issue of concern surrounding the use of Thalidomide?
What was the core issue of concern surrounding the use of Thalidomide?
Explain the significance of Dr. William McBride's role in the Thalidomide tragedy.
Explain the significance of Dr. William McBride's role in the Thalidomide tragedy.
The "Declaration of Helsinki" is focused on establishing ethical principles for human medical research and experimentation.
The "Declaration of Helsinki" is focused on establishing ethical principles for human medical research and experimentation.
What does "ICSR" stand for in the context of pharmacovigilance?
What does "ICSR" stand for in the context of pharmacovigilance?
What are the four minimum criteria for a valid adverse drug reaction report?
What are the four minimum criteria for a valid adverse drug reaction report?
What are "spontaneous reports" in the context of pharmacovigilance?
What are "spontaneous reports" in the context of pharmacovigilance?
What is the role of the marketing authorization holder in managing reports from non-medical sources?
What is the role of the marketing authorization holder in managing reports from non-medical sources?
What are "solicited reports" in the context of pharmacovigilance?
What are "solicited reports" in the context of pharmacovigilance?
What are the specific types of cases that are considered particularly relevant for follow-up?
What are the specific types of cases that are considered particularly relevant for follow-up?
What is the primary importance of identifying the name and batch number of a product in a suspected adverse reaction report?
What is the primary importance of identifying the name and batch number of a product in a suspected adverse reaction report?
How should electronic and paper reports of suspected adverse reactions be treated?
How should electronic and paper reports of suspected adverse reactions be treated?
What steps should be taken when a report containing identifiable personal details is submitted?
What steps should be taken when a report containing identifiable personal details is submitted?
How should reports involving exposure of pregnant women to medicinal products be managed?
How should reports involving exposure of pregnant women to medicinal products be managed?
Why are reports of exposure to medicinal products during pregnancy considered serious?
Why are reports of exposure to medicinal products during pregnancy considered serious?
What is the importance of collecting information on the age or age group of patients in pharmacovigilance?
What is the importance of collecting information on the age or age group of patients in pharmacovigilance?
What type of reports should be considered in periodic safety update reports, rather than being reported as ICSRs?
What type of reports should be considered in periodic safety update reports, rather than being reported as ICSRs?
What is the general timeframe for reporting serious valid ICSRs?
What is the general timeframe for reporting serious valid ICSRs?
If a case initially reported as "serious" becomes "non-serious" based on follow-up information, this updated information should be reported within 15 days.
If a case initially reported as "serious" becomes "non-serious" based on follow-up information, this updated information should be reported within 15 days.
Explain the concept of "biosimilars" in pharmacovigilance.
Explain the concept of "biosimilars" in pharmacovigilance.
What are the key considerations in pharmacovigilance for biosimilars compared to originator biologics?
What are the key considerations in pharmacovigilance for biosimilars compared to originator biologics?
What should a pharmacist do when they notice a turbidity in an ampoule of a drug?
What should a pharmacist do when they notice a turbidity in an ampoule of a drug?
What should a pharmacist do when a pregnant patient comes to the pharmacy with a prescription for Aspirin?
What should a pharmacist do when a pregnant patient comes to the pharmacy with a prescription for Aspirin?
What should a pharmacist do when a physician consults them about a metastatic breast cancer patient who has experienced unexpected progression of disease while on trastuzumab?
What should a pharmacist do when a physician consults them about a metastatic breast cancer patient who has experienced unexpected progression of disease while on trastuzumab?
What should a pharmacist do when a patient's daughter shares the news of her mother's death and informs the pharmacist that her mother was always taking medications from the pharmacy, including GLP-1 analogs, barbiturates, and low-dose aspirin?
What should a pharmacist do when a patient's daughter shares the news of her mother's death and informs the pharmacist that her mother was always taking medications from the pharmacy, including GLP-1 analogs, barbiturates, and low-dose aspirin?
What should a pharmacist do when a colleague expresses concerns about insufficient information on the preparation of benzamycin and doubts about making the wrong application?
What should a pharmacist do when a colleague expresses concerns about insufficient information on the preparation of benzamycin and doubts about making the wrong application?
What action should a pharmacist take when a patient wants to take propranolol for preventing anxiety before a presentation?
What action should a pharmacist take when a patient wants to take propranolol for preventing anxiety before a presentation?
What action should a pharmacist take when a colleague expresses concerns about the preparation of benzamycin?
What action should a pharmacist take when a colleague expresses concerns about the preparation of benzamycin?
What is the role of TÃœFAM in the pharmaceutical industry?
What is the role of TÃœFAM in the pharmaceutical industry?
What is the main reason for the strict regulation of retinoid drugs?
What is the main reason for the strict regulation of retinoid drugs?
What should a pharmacist do when they receive a report of an adverse event that relates to the use of a medication during pregnancy?
What should a pharmacist do when they receive a report of an adverse event that relates to the use of a medication during pregnancy?
Flashcards
Adverse Drug Reaction (ADR)
Adverse Drug Reaction (ADR)
Any harm associated with the use of drugs at normal dosages during normal use.
Adverse Drug Event (ADE)
Adverse Drug Event (ADE)
Any untoward medical occurrence that may present during treatment with a medicine, but might not have a causal relationship with this treatment.
Side Effect
Side Effect
An unintended effect of a pharmaceutical product at normal doses, related to the pharmacological properties of the drug.
Unexpected Adverse Drug Reaction
Unexpected Adverse Drug Reaction
Signup and view all the flashcards
Pharmacovigilance
Pharmacovigilance
Signup and view all the flashcards
What are the aims of pharmacovigilance?
What are the aims of pharmacovigilance?
Signup and view all the flashcards
Thalidomide Tragedy
Thalidomide Tragedy
Signup and view all the flashcards
Severity of ADRs
Severity of ADRs
Signup and view all the flashcards
Individual Case Safety Report (ICSR)
Individual Case Safety Report (ICSR)
Signup and view all the flashcards
Collection of ADR Reports
Collection of ADR Reports
Signup and view all the flashcards
Spontaneous Report
Spontaneous Report
Signup and view all the flashcards
Literature Reports
Literature Reports
Signup and view all the flashcards
Reports from Solicited Sources
Reports from Solicited Sources
Signup and view all the flashcards
Follow-up of ADR Reports
Follow-up of ADR Reports
Signup and view all the flashcards
Data Management
Data Management
Signup and view all the flashcards
Special Situations in ADR Reporting
Special Situations in ADR Reporting
Signup and view all the flashcards
Type A ADRs (Augmented Pharmacological Effects)
Type A ADRs (Augmented Pharmacological Effects)
Signup and view all the flashcards
Type B ADRs (Bizarre Effects)
Type B ADRs (Bizarre Effects)
Signup and view all the flashcards
Type C ADRs (Chronic Effects)
Type C ADRs (Chronic Effects)
Signup and view all the flashcards
Type D ADRs (Delayed Effects)
Type D ADRs (Delayed Effects)
Signup and view all the flashcards
Type E ADRs (End-of-Treatment Effects)
Type E ADRs (End-of-Treatment Effects)
Signup and view all the flashcards
Type F ADRs (Failure of Therapy)
Type F ADRs (Failure of Therapy)
Signup and view all the flashcards
Type G ADRs (Genetic Reactions)
Type G ADRs (Genetic Reactions)
Signup and view all the flashcards
Possible Causes of ADRs
Possible Causes of ADRs
Signup and view all the flashcards
Biosimilar
Biosimilar
Signup and view all the flashcards
Pharmacovigilance System
Pharmacovigilance System
Signup and view all the flashcards
TÜFAM (Türkiye Farmakovijilans Merkezi)
TÜFAM (Türkiye Farmakovijilans Merkezi)
Signup and view all the flashcards
Study Notes
Introduction to Pharmacovigilance
- Pharmacovigilance combines "pharmaco" (medicine) and "vigilance" (to watch)
- It is the science and activities related to the detection, evaluation, understanding, and prevention of adverse drug reactions (ADRs) and other drug-related problems.
- Modern concerns include herbs, traditional remedies, blood products, biological devices, and vaccines.
Aims of Pharmacovigilance
- Early detection of unknown safety problems
- Identification of increases in frequency of problems
- Identification of risk factors
- Quantification of risks
- Prevention of patients from unnecessary harm
History and Terminology in Pharmacovigilance
- Historical examples, like the Biologics Control Act (1902) and Elixir of Sulfanilamide tragedy (1937), highlight the need for pharmacovigilance.
- Thalidomide tragedy (1960s) highlighted the need for intensified drug safety testing and regulation.
- Key terms like ICSR (individual case safety report) and ADR (adverse drug reaction) are foundational to understanding pharmacovigilance.
- Adverse Drug Reaction (ADR) - Any harm associated with normal drug use
- Adverse Drug Event (ADE) - Any untoward medical occurrence during treatment
- Side Effect - Any unintended consequence of medications
- Unexpected Adverse Drug Reaction (UADR) - Unexpected reactions that aren't expected from drug characteristics
Classification of ADRs
- Type A: Augmented/predictable effects (dose-dependent)
- Type B: Bizarre/unpredictable effects (dose-independent)
- Type C: Chronic effects
- Type D: Delayed effects
- Type E: End-of-treatment effects
- Type F: Failure of therapy
- Type G: Genetic reactions
Possible Causes of ADRs
- Intrinsic factors: Idiosyncrasy, mutagenicity, carcinogenicity, teratogenicity.
- Extrinsic factors: Adulterations, contamination
- Underlying medical conditions, Interactions, and Wrong use
Examples of Drug Recalls/Adverse Events
- Thalidomide (1965): birth defects
- Practolol (1975): sclerosing peritonitis and lactic acidosis
- Phenformin (1982): lactic acidosis
- Rofecoxib (2004): cardiovascular effects
- Veralipride (2007): anxiety, depression, and movement disorders
- Rosiglitazone (2010): increased risk of myocardial infarction (MI) and death from cardiovascular (CV) causes
Severity of ADRs
- Minor: No need for therapy
- Moderate: Requires change in drug/treatment, and potential hospitalization
- Severe: Potentially life-threatening, permanent damage, and/or prolonged hospitalization
- Lethal: Directly or indirectly leads to death
Reporting ADRs
- ICSR: Individual case safety report
- Information involving one or more suspected adverse reactions from a single patient.
Collection of Reports
- Spontaneous reports: Unrequested communications from healthcare professionals or consumers.
- Reports from literature: Scientific journals.
- Reports from other sources: News, social media, etc.
- Solicited reports: Organized data collection (clinical trials, registries)
Follow-up of Reports
- Follow-up is essential to obtain more detailed information that can aid in scientific evaluation.
- Reports linked to pregnancy are vital.
Data Management
- Electronic and paper reports must be managed with patient confidentiality prioritized.
Special Situations
- Pregnancy: Exposure of embryo/fetus necessitates monitoring the pregnancy's outcome & child development
- Pediatric/Elderly: Reports should note the patient's age to identify potential safety signals specific to these groups
- Off-label use: Reports of suspected off-label use that doesn't relate to established indication
Reporting Timeframes
- Reporting of serious adverse events (valid ICSRs) ideally as soon as possible but no later than 15 days after initial receipt of the information.
Biosimilars
- Biosimilar products are similar to reference biotherapeutic products in quality, efficacy, and safety.
Clinical Trial Stages
- Preclinical studies: Long term studies.
- Phase 1: Very small studies with volunteers to assess safety.
- Phase 2: Slightly larger studies to evaluate efficacy.
- Phase 3: Larger and extensively tested in various populations.
- Phase 4: Post-market surveillance monitors long-term effects and new safety issues during marketing
Lack of Therapeutic Efficacy
- Reports of inadequate therapeutic effects need to be recorded, followed-up if data is incomplete
Medication Errors
- Errors in prescribing, dispensing, or administration of medication
Examples of Specific Drug-Related Cases (Situations)
- Cases that involve specific drug reactions (e.g. a patient with a particular condition or reaction)
Additional Information
- The importance of understanding the specific contexts of situations.
- These contexts should be discussed in the report in more detail.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Related Documents
Description
This quiz explores the fundamental concepts of pharmacovigilance, including its aims, history, and key terminology. It provides an overview of the importance of monitoring drug safety to prevent adverse effects and protect patients. Dive deep into the evolution of pharmacovigilance through historical events that shaped its current practices.